Shahinaz Mohamed Aly Gadalla is a physician-scientist and cancer epidemiologist who researches cancer biomarkers and hematopoietic stem cell transplantation. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Shahinaz Gadalla | |
|---|---|
 Gadalla in 2015 | |
| Alma mater | Ain Shams University Faculty of Medicine University of Maryland, Baltimore |
| Scientific career | |
| Fields | Epidemiology, cancer biomarkers, hematopoietic stem cell transplantation |
| Institutions | National Cancer Institute |
Life
editShahinaz Mohamed Aly Gadalla was born to Mohamed and Sabah.[1] She earned a M.B.Bch from Ain Shams University Faculty of Medicine In 1996.[1][2] She completed a medical internship in 1998 at Ain Shams University Hospitals.[1] Gadallah completed a M.S. (2005) in epidemiology and preventative medicine and a Ph.D. (2008) in epidemiology from the University of Maryland, Baltimore.[1][2] Her dissertation was titled, Systemic autoimmune rheumatic diseases and breast cancer risk in elderly women.[1] Sania Amr was her doctoral advisor.[1] Gadalla dedicated her dissertation to her daughter.[1] She joined the clinical genetics branch (CGB) within the National Cancer Institute (NCI) division of cancer epidemiology and genetics as a cancer prevention fellow in 2008.[2]
Gadalla was promoted to a staff scientist in 2011 and was appointed as an Earl Stadtman Tenure-Track Investigator in 2014.[2] She was awarded National Institutes of Health (NIH) scientific tenure and appointed senior investigator in 2022.[2] Gadalla's research interests focus on identifying and characterizing individuals at high risk of developing cancer and discovering predictive and prognostic biomarkers that may guide therapeutic decisions for those patients.[2] In 2011, Gadalla and colleagues were the first to report epidemiological evidence of excess cancer risk in myotonic dystrophy (DM) patients.[2] She also researches molecular predictors of outcomes after hematopoietic cell transplantation.[2] Gadalla's work focuses on severe aplastic anemia and myeloid neoplasms with a goal of identifying biomarkers that can guide donor selection or patient risk stratification.[2] Her investigations include markers of cellular aging, germline genetic variants, and somatic copy-number alterations.[2]
References
edit- ^ a b c d e f g Gadalla, Shahinaz M. (2008). Systemic autoimmune rheumatic diseases and breast cancer risk in elderly women (Ph.D. thesis). University of Maryland, Baltimore. OCLC 7068882810.
- ^ a b c d e f g h i j "Shahinaz Gadalla, M.D., Ph.D., biographical sketch and research interests - NCI". dceg.cancer.gov. 1980-01-01. Retrieved 2022-10-17.
This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.